Fig. 3From: Serum α-hydroxybutyrate dehydrogenase as a biomarker for predicting survival outcomes in patients with UTUC after radical nephroureterectomyCalibration curves of 3-year and 5-year cancer-specific survival (a) and ROC curve for assessing the calibration and discrimination of the nomogram in predicting 3-year or 5-year cancer-specific survival (b)Back to article page